Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $8.99 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 43.19.
Market Cap
8.99T
Revenue
4.62T
Profits
208.25B
PE Ratio
43.19
Profit Margin
4.51%
Dividend Yield
0.40%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.53% | 2,884,624 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 617.78B | 0.21% | 6,782,061 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 443.36B | -2.51% | 7,258,025 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 376.34B | -1.68% | 3,919,896 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 321.57B | 0.32% | 7,738,763 | 65.77B |
| 6 | NVS | Novartis AG | 297.39B | -1.45% | 1,546,268 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.74B | -0.99% | 1,670,007 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 212.35B | -0.43% | 2,112,918 | 46.34B |
| 9 | NVO | Novo Nordisk A/S | 208.62B | -8.78% | 26,798,019 | 50.57B |
| 10 | AMGN | Amgen Inc. | 207.87B | -0.64% | 1,954,534 | 37.22B |
| 11 | ABT | Abbott Laboratories | 182.90B | 0.09% | 9,610,067 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 161.66B | -0.82% | 6,499,842 | 29.74B |
| 13 | PFE | Pfizer Inc. | 142.54B | 0.40% | 45,079,935 | 63.32B |
| 14 | DHR | Danaher Corporation | 137.07B | -0.61% | 4,387,575 | 25.11B |
| 15 | BMY | Bristol-Myers Squibb Company | 133.41B | 0.69% | 14,580,206 | 49.19B |
| 16 | CVS | CVS Health Corporation | 133.25B | -0.75% | 7,081,278 | 405.62B |
| 17 | SYK | Stryker Corporation | 124.93B | -6.42% | 4,536,531 | 25.84B |
| 18 | ISRG | Intuitive Surgical, Inc. | 124.82B | 0.10% | 2,459,562 | 11.03B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 121.09B | -0.95% | 957,641 | 12.22B |
| 20 | MDT | Medtronic plc | 109.30B | -0.37% | 9,605,185 | 36.36B |
| 21 | GSK | GSK plc | 103.55B | -0.73% | 3,982,165 | 44.05B |
| 22 | SNY | Sanofi | 102.63B | 0.44% | 2,943,338 | 55.89B |
| 23 | MCK | McKesson Corporation | 100.24B | -1.08% | 773,569 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.16B | 1.72% | 1,256,344 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 81.51B | -0.15% | 977,235 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.15B | 3.29% | 1,158,558 | 15.53B |
| 27 | CI | The Cigna Group | 73.74B | -2.99% | 2,189,875 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.46B | 1.59% | 18,691,768 | 21.00B |
| 29 | COR | Cencora, Inc. | 60.57B | -0.29% | 1,048,288 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.24B | -0.93% | 4,109,515 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 53.87B | 1.30% | 1,738,075 | 250.74B |
| 32 | ARGX | argenx SE | 53.60B | -2.15% | 294,612 | 5.32B |
| 33 | MDLN | Medline Inc. | 51.60B | 0.41% | 4,032,274 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 49.56B | -0.98% | 3,952,947 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 45.64B | 0.10% | 2,025,130 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.10B | 0.05% | 630,586 | 4.45B |
| 37 | HUM | Humana Inc. | 43.69B | -0.76% | 1,454,827 | 145.68B |
| 38 | HLN | Haleon plc | 43.08B | -2.37% | 10,997,923 | 14.80B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.80B | -1.13% | 4,695,343 | 17.32B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.87B | -2.41% | 1,491,781 | - |
| 41 | A | Agilent Technologies, Inc. | 39.08B | -0.25% | 1,721,009 | 7.23B |
| 42 | IQV | IQVIA Holdings Inc. | 38.68B | -1.16% | 1,321,995 | 16.98B |
| 43 | NTRA | Natera, Inc. | 38.35B | -0.70% | 1,331,236 | 2.50B |
| 44 | WAT | Waters Corporation | 37.05B | -0.79% | 715,254 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.13B | -1.88% | 249,899 | 5.74B |
| 46 | RPRX | Royalty Pharma plc | 33.65B | -1.00% | 2,156,846 | 2.44B |
| 47 | ALC | Alcon Inc. | 33.38B | -0.96% | 2,315,633 | 10.63B |
| 48 | VEEV | Veeva Systems Inc. | 33.10B | 1.10% | 1,888,811 | 3.32B |
| 49 | ZTS | Zoetis Inc. | 32.40B | 1.66% | 5,018,256 | 9.53B |
| 50 | DXCM | DexCom, Inc. | 31.49B | 11.95% | 11,978,921 | 4.97B |
| 51 | ILMN | Illumina, Inc. | 30.97B | - | 4,095,700 | 4.49B |
| 52 | CNC | Centene Corporation | 30.74B | 2.27% | 3,913,488 | 180.30B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 30.72B | -2.75% | 5,115,826 | 21.27B |
| 54 | RMD | ResMed Inc. | 30.43B | 1.16% | 1,113,639 | 5.54B |
| 55 | BIIB | Biogen Inc. | 29.99B | -2.40% | 1,062,257 | 10.03B |
| 56 | MTD | Mettler-Toledo International Inc. | 28.38B | 2.59% | 257,257 | 4.13B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 27.50B | 0.02% | 4,477,535 | 4.80B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.72B | -0.55% | 872,677 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.57B | -0.53% | 1,306,820 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 25.01B | -2.01% | 1,091,255 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.39B | -1.77% | 5,397,049 | 8.26M |
| 62 | INCY | Incyte Corporation | 24.23B | -2.82% | 1,829,492 | 5.82B |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.00B | 0.40% | 1,047,591 | 3.33B |
| 64 | BNTX | BioNTech SE | 22.91B | -2.44% | 710,893 | 3.23B |
| 65 | STE | STERIS plc | 22.26B | -1.22% | 828,101 | 5.94B |
| 66 | UTHR | United Therapeutics Corporation | 21.98B | -1.54% | 616,613 | 3.17B |
| 67 | MRNA | Moderna, Inc. | 21.89B | -5.35% | 7,764,504 | 2.23B |
| 68 | GH | Guardant Health, Inc. | 21.74B | 6.33% | 4,565,898 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.37B | -2.85% | 2,899,367 | 819.56M |
| 70 | THC | Tenet Healthcare Corporation | 20.51B | 0.81% | 1,098,500 | 21.81B |
| 71 | VTRS | Viatris Inc. | 20.45B | -1.13% | 15,567,196 | 14.56B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.17B | -1.08% | 2,773,017 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.56B | 0.80% | 2,057,334 | 3.90B |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 16.96B | -10.08% | 4,590,615 | 3.37B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.11B | -0.21% | 261,427 | 2.78B |
| 76 | ASND | Ascendis Pharma A/S | 16.08B | -2.85% | 508,875 | 998.25M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.88B | -2.14% | 572,224 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.66B | -2.50% | 2,132,592 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.41B | 0.51% | 426,613 | 13.84B |
| 80 | SOLV | Solventum Corporation | 14.80B | -1.59% | 1,056,906 | 8.26B |
| 81 | COO | The Cooper Companies, Inc. | 14.10B | -0.45% | 2,518,356 | 4.23B |
| 82 | FMS | Fresenius Medical Care AG | 13.55B | -0.16% | 513,511 | 22.32B |
| 83 | BAX | Baxter International Inc. | 13.52B | -2.21% | 9,282,801 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.33B | -5.25% | 3,025,174 | 2.38B |
| 85 | ELAN | Elanco Animal Health Incorporated | 13.17B | -0.34% | 5,193,855 | 4.89B |
| 86 | SNN | Smith & Nephew plc | 13.12B | -2.38% | 1,842,851 | 6.16B |
| 87 | PEN | Penumbra, Inc. | 12.65B | 0.43% | 295,954 | 1.50B |
| 88 | ICLR | ICON Public Limited Company | 12.62B | -1.19% | 862,092 | 8.29B |
| 89 | RVTY | Revvity, Inc. | 12.55B | -0.90% | 1,204,254 | 2.90B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.52B | -18.07% | 7,735,427 | 14.37B |
| 91 | CORT | Corcept Therapeutics Incorporated | 12.38B | -3.24% | 1,840,751 | 830.81M |
| 92 | ALGN | Align Technology, Inc. | 12.11B | -2.45% | 1,608,275 | 4.14B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.92B | -3.06% | 1,657,344 | 622.01M |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | -0.92% | 2,377,098 | 3.24B |
| 95 | PODD | Insulet Corporation | 11.45B | -0.20% | 1,314,001 | 2.90B |
| 96 | TECH | Bio-Techne Corporation | 11.23B | 0.08% | 4,033,711 | 1.21B |
| 97 | AXSM | Axsome Therapeutics, Inc. | 11.22B | -7.10% | 781,964 | 708.24M |
| 98 | CRL | Charles River Laboratories International, Inc. | 11.20B | -0.90% | 509,242 | 4.03B |
| 99 | EHC | Encompass Health Corporation | 11.02B | 0.16% | 503,672 | 6.07B |
| 100 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.80B | -5.23% | 795,229 | 1.28B |
| 101 | GMED | Globus Medical, Inc. | 10.70B | -1.83% | 1,054,232 | 3.10B |
| 102 | ABVX | ABIVAX Société Anonyme | 10.54B | 0.47% | 1,237,666 | 5.67M |
| 103 | CYTK | Cytokinetics, Incorporated | 10.47B | -4.09% | 1,579,040 | 105.82M |
| 104 | SMMT | Summit Therapeutics Inc. | 10.39B | -3.12% | 3,995,115 | - |
| 105 | ENSG | The Ensign Group, Inc. | 10.30B | -0.37% | 420,516 | 5.49B |
| 106 | UHS | Universal Health Services, Inc. | 10.20B | 3.15% | 1,344,989 | 18.11B |
| 107 | MOH | Molina Healthcare, Inc. | 10.19B | 0.47% | 680,652 | 42.47B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.16% | 1,744,241 | - |
| 109 | KRYS | Krystal Biotech, Inc. | 10.06B | -7.01% | 488,404 | 417.30M |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.01B | 0.17% | 3,009,493 | 3.50B |
| 111 | GKOS | Glaukos Corporation | 9.83B | -1.07% | 1,032,218 | 612.84M |
| 112 | HALO | Halozyme Therapeutics, Inc. | 9.79B | -0.91% | 1,558,885 | 1.51B |
| 113 | HSIC | Henry Schein, Inc. | 9.77B | 0.68% | 1,219,956 | 13.38B |
| 114 | BRKR | Bruker Corporation | 9.57B | -2.33% | 1,731,398 | 3.46B |
| 115 | OSCR | Oscar Health, Inc. | 9.40B | -0.03% | 3,448,465 | 13.30B |
| 116 | AVTR | Avantor, Inc. | 9.32B | -0.58% | 12,415,837 | 6.56B |
| 117 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | -0.13% | 1,863,652 | 18.07M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 8.79B | -1.44% | 548,760 | 74.06M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 8.71B | -0.38% | 190,103 | 2.59B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.65B | -3.12% | 613,606 | - |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 8.60B | -2.83% | 2,567,378 | 874.09M |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.58B | 0.03% | 385,139 | 7.46M |
| 123 | QGEN | Qiagen N.V. | 8.56B | -0.12% | 1,339,862 | 2.10B |
| 124 | ATR | AptarGroup, Inc. | 8.52B | 0.07% | 886,404 | 3.93B |
| 125 | KYMR | Kymera Therapeutics, Inc. | 8.51B | -3.37% | 509,566 | 51.48M |
| 126 | HQY | HealthEquity, Inc. | 8.41B | -0.38% | 526,877 | 1.34B |
| 127 | ALKS | Alkermes plc | 8.22B | -2.08% | 1,624,486 | 1.67B |
| 128 | IMVT | Immunovant, Inc. | 7.97B | -2.18% | 668,305 | - |
| 129 | RGEN | Repligen Corporation | 7.96B | -1.80% | 875,258 | 785.10M |
| 130 | TEM | Tempus AI, Inc. | 7.92B | -0.95% | 7,310,576 | 1.43B |
| 131 | PCVX | Vaxcyte, Inc. | 7.81B | -3.36% | 793,219 | - |
| 132 | IBRX | ImmunityBio, Inc. | 7.51B | -3.76% | 9,319,004 | 140.98M |
| 133 | LQDA | Liquidia Corporation | 7.48B | -3.10% | 1,131,962 | 288.07M |
| 134 | TGTX | TG Therapeutics, Inc. | 7.37B | -2.80% | 2,489,739 | 700.35M |
| 135 | PACS | PACS Group, Inc. | 7.28B | -2.09% | 798,662 | 5.43B |
| 136 | CHE | Chemed Corporation | 6.93B | -0.47% | 221,553 | 2.60B |
| 137 | GRFS | Grifols, S.A. | 6.84B | -4.02% | 484,453 | 8.48B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.80B | -6.14% | 471,702 | 217.17M |
| 139 | COGT | Cogent Biosciences, Inc. | 6.65B | -5.88% | 1,547,105 | - |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.49B | -1.35% | 1,022,015 | 1.55B |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.46B | -5.90% | 578,721 | 569.61M |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.43B | 2.70% | 12,585,138 | 2.37B |
| 143 | BLLN | BillionToOne, Inc. | 6.37B | -0.71% | 531,107 | 354.54M |
| 144 | ERAS | Erasca, Inc. | 6.30B | -2.84% | 2,696,382 | - |
| 145 | CGON | CG Oncology, Inc. | 6.28B | -2.52% | 560,803 | 5.07M |
| 146 | BLTE | Belite Bio, Inc | 6.24B | -0.82% | 159,281 | - |
| 147 | XENE | Xenon Pharmaceuticals Inc. | 6.06B | -2.37% | 736,904 | 7.50M |
| 148 | TFX | Teleflex Incorporated | 6.05B | 3.33% | 558,083 | 2.13B |
| 149 | BLCO | Bausch + Lomb Corporation | 6.04B | -0.47% | 469,235 | 5.32B |
| 150 | TXG | 10x Genomics, Inc. | 6.00B | -4.37% | 2,869,245 | 638.78M |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 5.84B | -5.08% | 1,075,498 | 1.34M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.84B | -0.97% | 2,011,709 | 3.12B |
| 153 | ORKA | Oruka Therapeutics, Inc. | 5.82B | -1.38% | 758,753 | - |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.80B | -4.94% | 1,029,801 | 840.85M |
| 155 | HNGE | Hinge Health, Inc. | 5.78B | -0.53% | 1,127,820 | 646.34M |
| 156 | DFTX | Definium Therapeutics, Inc. | 5.78B | -2.18% | 1,965,585 | - |
| 157 | TWST | Twist Bioscience Corporation | 5.70B | 0.24% | 1,494,153 | 409.48M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.70B | -2.95% | 271,962 | 274.48M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.68B | -9.94% | 4,329,486 | 1.01B |
| 160 | SRRK | Scholar Rock Holding Corporation | 5.67B | -3.46% | 786,736 | - |
| 161 | STVN | Stevanato Group S.p.A. | 5.42B | -1.73% | 204,076 | 1.39B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.20B | -2.43% | 1,715,028 | 536.20M |
| 163 | SHC | Sotera Health Company | 5.09B | 0.06% | 1,514,718 | 1.19B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.08B | 1.99% | 2,201,090 | 1.58B |
| 165 | MMED | MiniMed Group, Inc. | 5.07B | -0.55% | 613,415 | 3.10B |
| 166 | RDNT | RadNet, Inc. | 5.02B | 1.74% | 596,121 | 2.14B |
| 167 | INDV | Indivior Pharmaceuticals, Inc. | 4.88B | -0.52% | 1,349,357 | 1.29B |
| 168 | CRSP | CRISPR Therapeutics AG | 4.73B | -0.93% | 1,036,224 | 4.10M |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.70B | -2.14% | 1,824,986 | - |
| 170 | NVST | Envista Holdings Corporation | 4.44B | -1.69% | 3,160,586 | 2.81B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.43B | -2.56% | 1,534,198 | 1.10B |
| 172 | CAI | Caris Life Sciences, Inc. | 4.43B | -2.61% | 3,511,207 | 907.29M |
| 173 | LIVN | LivaNova PLC | 4.40B | -1.12% | 505,725 | 1.43B |
| 174 | MANE | Veradermics, Incorporated | 4.39B | 0.35% | 918,406 | - |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.33B | 5.27% | 355,898 | - |
| 176 | CELC | Celcuity Inc. | 4.21B | -1.44% | 677,931 | - |
| 177 | ICUI | ICU Medical, Inc. | 4.21B | 0.08% | 349,475 | 2.16B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | -6.54% | 1,150,032 | - |
| 179 | ITGR | Integer Holdings Corporation | 4.12B | 20.18% | 2,610,056 | 1.86B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.10B | -3.19% | 1,785,597 | 10.68M |
| 181 | LFST | LifeStance Health Group, Inc. | 4.06B | -2.42% | 2,520,047 | 1.49B |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.05B | 0.09% | 556,927 | 2.23B |
| 183 | WAY | Waystar Holding Corp. | 4.05B | 0.81% | 3,860,861 | 1.21B |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.93B | -1.41% | 1,687,575 | 56.99M |
| 185 | HAE | Haemonetics Corporation | 3.89B | 0.85% | 789,607 | 1.33B |
| 186 | IRTC | iRhythm Holdings, Inc. | 3.85B | -1.60% | 466,190 | 787.85M |
| 187 | ELVN | Enliven Therapeutics, Inc. | 3.83B | 1.59% | 660,413 | - |
| 188 | DOCS | Doximity, Inc. | 3.76B | -1.55% | 2,726,225 | 644.86M |
| 189 | VCYT | Veracyte, Inc. | 3.72B | -22.52% | 5,994,803 | 561.90M |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.70B | -4.14% | 1,867,338 | - |
| 191 | DNLI | Denali Therapeutics Inc. | 3.65B | -5.46% | 1,231,814 | - |
| 192 | ALMS | Alumis Inc. | 3.60B | -2.42% | 1,321,120 | 8.40M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 3.59B | -6.66% | 2,993,108 | 308.08M |
| 194 | LEGN | Legend Biotech Corporation | 3.59B | -2.62% | 2,718,056 | 1.14B |
| 195 | OGN | Organon & Co. | 3.56B | - | 2,689,351 | 6.13B |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.55B | -0.21% | 1,270,691 | 236.00M |
| 197 | NHC | National HealthCare Corporation | 3.53B | -1.28% | 85,772 | 1.53B |
| 198 | BKD | Brookdale Senior Living Inc. | 3.49B | -0.14% | 3,694,110 | 3.00B |
| 199 | OPCH | Option Care Health, Inc. | 3.45B | 2.54% | 3,435,232 | 5.69B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.41B | -2.89% | 407,245 | - |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.39B | -1.69% | 80,919 | 803.79M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.38B | -2.47% | 479,797 | 225.27M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -4.04% | 1,548,715 | 415.62M |
| 204 | WRBY | Warby Parker Inc. | 3.28B | 2.57% | 1,360,670 | 890.57M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | -2.35% | 956,575 | 22.57M |
| 206 | MBX | MBX Biosciences, Inc. | 3.14B | -0.80% | 565,807 | - |
| 207 | ALHC | Alignment Healthcare, Inc. | 3.08B | -20.20% | 17,475,267 | 4.58B |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.06B | 4.04% | 191,708 | - |
| 209 | QURE | uniQure N.V. | 3.03B | 3.41% | 1,695,179 | 18.67M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 2.99B | -1.12% | 875,347 | 865.00K |
| 211 | PRVA | Privia Health Group, Inc. | 2.98B | -0.80% | 969,156 | 2.25B |
| 212 | IRON | Disc Medicine, Inc. | 2.96B | -2.79% | 363,764 | - |
| 213 | GRAL | GRAIL, Inc. | 2.94B | -3.63% | 560,077 | 156.12M |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.76B | 5.26% | 2,182,120 | 3.37B |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.72B | -1.01% | 323,517 | 229.58M |
| 216 | XRAY | DENTSPLY SIRONA Inc. | 2.68B | -2.69% | 3,632,696 | 3.68B |
| 217 | ATAI | AtaiBeckley Inc. | 2.66B | - | 8,917,253 | 3.49M |
| 218 | TMDX | TransMedics Group, Inc. | 2.64B | 0.50% | 532,471 | 635.89M |
| 219 | NEOG | Neogen Corporation | 2.63B | 4.42% | 3,801,974 | 870.40M |
| 220 | KOD | Kodiak Sciences Inc. | 2.60B | -2.16% | 426,202 | - |
| 221 | TRVI | Trevi Therapeutics, Inc. | 2.59B | -0.82% | 1,350,334 | - |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | -2.15% | 573,624 | 776.83M |
| 223 | IMNM | Immunome, Inc. | 2.58B | -1.39% | 657,786 | 4.02M |
| 224 | BHC | Bausch Health Companies Inc. | 2.58B | 14.26% | 22,803,842 | 10.85B |
| 225 | BEAM | Beam Therapeutics Inc. | 2.54B | -3.66% | 1,068,071 | 164.01M |
| 226 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -0.84% | 637,019 | 535.08M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -4.05% | 431,329 | 1.46B |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -4.34% | 1,537,765 | 670.00M |
| 229 | PGNY | Progyny, Inc. | 2.44B | -1.14% | 974,521 | 1.29B |
| 230 | PLSE | Pulse Biosciences, Inc. | 2.43B | 0.26% | 277,943 | 751.00K |
| 231 | NRIX | Nurix Therapeutics, Inc. | 2.41B | -1.57% | 761,615 | 36.77M |
| 232 | NKTR | Nektar Therapeutics | 2.39B | -1.09% | 497,059 | 55.63M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.38B | 0.54% | 392,950 | 1.09B |
| 234 | VCEL | Vericel Corporation | 2.35B | -3.47% | 521,407 | 306.30M |
| 235 | LMAT | LeMaitre Vascular, Inc. | 2.32B | -0.85% | 233,741 | 256.28M |
| 236 | VERA | Vera Therapeutics, Inc. | 2.30B | -2.87% | 1,443,691 | - |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | -2.81% | 2,929,184 | 885.72M |
| 238 | PHVS | Pharvaris N.V. | 2.28B | -3.72% | 507,253 | - |
| 239 | AXGN | Axogen, Inc. | 2.27B | 2.08% | 1,223,540 | 251.17M |
| 240 | CDNA | CareDx, Inc. | 2.26B | 14.72% | 2,780,188 | 458.09M |
| 241 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.26B | -2.12% | 1,832,461 | -665.00K |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -2.56% | 618,119 | - |
| 243 | PGEN | Precigen, Inc. | 2.24B | 5.56% | 5,624,066 | 31.60M |
| 244 | COAG | Hemab Therapeutics Holdings, Inc. | 2.22B | 0.17% | 447,272 | - |
| 245 | NUVB | Nuvation Bio Inc. | 2.20B | -5.52% | 4,890,889 | 143.05M |
| 246 | CLOV | Clover Health Investments, Corp. | 2.20B | -3.92% | 3,542,299 | 2.21B |
| 247 | KLRA | Kailera Therapeutics, Inc. | 2.19B | -0.65% | 411,267 | - |
| 248 | HTFL | HeartFlow, Inc. | 2.18B | -2.32% | 684,828 | 191.42M |
| 249 | SION | Sionna Therapeutics, Inc. | 2.13B | 0.75% | 392,309 | - |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.13B | 0.11% | 453,563 | 1.93B |
| 251 | ADUS | Addus HomeCare Corporation | 2.11B | -1.03% | 155,005 | 1.45B |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.09B | -4.92% | 1,088,027 | 70.92M |
| 253 | ZLAB | Zai Lab Limited | 2.05B | 0.33% | 353,712 | 453.28M |
| 254 | AVAH | Aveanna Healthcare Holdings Inc. | 2.04B | -3.10% | 1,733,820 | 2.52B |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -1.73% | 604,686 | 899.11M |
| 256 | BHVN | Biohaven Ltd. | 2.03B | -2.32% | 1,429,647 | - |
| 257 | SGRY | Surgery Partners, Inc. | 2.00B | -3.14% | 1,138,179 | 3.34B |
| 258 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -7.42% | 185,670 | - |
| 259 | HCM | HUTCHMED (China) Limited | 1.99B | 3.34% | 38,540 | 549.12M |
| 260 | ZBIO | Zenas BioPharma, Inc. | 1.98B | -2.57% | 452,226 | 10.00M |
| 261 | UFPT | UFP Technologies, Inc. | 1.97B | -0.10% | 121,159 | 608.85M |
| 262 | SLS | SELLAS Life Sciences Group, Inc. | 1.97B | -2.72% | 5,043,890 | - |
| 263 | NBTX | Nanobiotix S.A. | 1.97B | -4.42% | 129,986 | 38.27M |
| 264 | NEO | NeoGenomics, Inc. | 1.96B | -3.72% | 3,035,354 | 766.30M |
| 265 | ADMA | ADMA Biologics, Inc. | 1.96B | -2.42% | 1,619,877 | 509.86M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.96B | -4.21% | 240,878 | 20.00M |
| 267 | WGS | GeneDx Holdings Corp. | 1.93B | -5.58% | 885,567 | 442.68M |
| 268 | GHRS | GH Research PLC | 1.93B | -1.09% | 177,769 | - |
| 269 | ATRC | AtriCure, Inc. | 1.92B | -5.95% | 1,310,569 | 569.62M |
| 270 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | -0.80% | 1,655,486 | 298.30M |
| 271 | TYRA | Tyra Biosciences, Inc. | 1.90B | -3.57% | 712,719 | - |
| 272 | BFLY | Butterfly Network, Inc. | 1.89B | -12.97% | 10,892,427 | 112.14M |
| 273 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.50% | 320,957 | 367.34M |
| 274 | TSHA | Taysha Gene Therapies, Inc. | 1.87B | -0.34% | 2,287,897 | 7.47M |
| 275 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.49% | 794,042 | - |
| 276 | MESO | Mesoblast Limited | 1.87B | -2.61% | 159,413 | 65.38M |
| 277 | URGN | UroGen Pharma Ltd. | 1.86B | -6.94% | 814,677 | 140.49M |
| 278 | KARD | Kardigan, Inc. | 1.86B | 1.71% | 280,613 | - |
| 279 | FTRE | Fortrea Holdings Inc. | 1.82B | 0.47% | 1,910,837 | 2.68B |
| 280 | IOVA | Iovance Biotherapeutics, Inc. | 1.82B | -13.22% | 19,940,923 | 285.61M |
| 281 | LKFT | Lakefront Biotherapeutics NV | 1.81B | -1.56% | 176,795 | 1.20B |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.80B | -3.93% | 715,803 | 32.08M |
| 283 | GENB | Generate Biomedicines, Inc. | 1.79B | -0.21% | 318,336 | 30.30M |
| 284 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -8.34% | 2,101,901 | 98.34M |
| 285 | OCUL | Ocular Therapeutix, Inc. | 1.79B | -3.54% | 2,151,848 | 52.04M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.78B | -0.75% | 314,511 | - |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.78B | 3.16% | 690,011 | - |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.76B | 1.16% | 154,363 | 87.16M |
| 289 | ABCL | AbCellera Biologics Inc. | 1.74B | 0.35% | 5,011,667 | 79.21M |
| 290 | NVCR | NovoCure Limited | 1.73B | -2.56% | 1,228,621 | 699.19M |
| 291 | IMCR | Immunocore Holdings plc | 1.72B | -0.18% | 761,726 | 412.81M |
| 292 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -2.67% | 1,087,352 | 204.73M |
| 293 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -2.21% | 1,206,281 | 217.17M |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | -1.48% | 205,144 | 923.71M |
| 295 | ENOV | Enovis Corporation | 1.68B | -0.51% | 770,260 | 2.28B |
| 296 | TRLV | Trulieve Cannabis Corp. | 1.66B | 0.93% | 712,094 | 1.17B |
| 297 | OMCL | Omnicell, Inc. | 1.61B | -4.69% | 1,120,832 | 1.25B |
| 298 | ASTH | Astrana Health, Inc. | 1.60B | -3.05% | 632,262 | 3.53B |
| 299 | HCSG | Healthcare Services Group, Inc. | 1.60B | 0.95% | 561,118 | 1.86B |
| 300 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -1.32% | 15,329,356 | 66.41M |
| 301 | AAPG | Ascentage Pharma Group International | 1.59B | -3.57% | 4,001 | 82.08M |
| 302 | ANAB | AnaptysBio, Inc. | 1.58B | -3.05% | 451,303 | 232.39M |
| 303 | ZYME | Zymeworks Inc. | 1.57B | -3.39% | 375,123 | 81.26M |
| 304 | SRPT | Sarepta Therapeutics, Inc. | 1.57B | -4.50% | 3,603,368 | 2.18B |
| 305 | SEPN | Septerna, Inc. | 1.55B | -2.08% | 241,069 | 72.26M |
| 306 | INVA | Innoviva, Inc. | 1.55B | -1.18% | 505,256 | 420.69M |
| 307 | INNV | InnovAge Holding Corp. | 1.54B | -2.07% | 351,216 | 949.17M |
| 308 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | -7.83% | 869,660 | - |
| 309 | CMPS | COMPASS Pathways plc | 1.53B | -1.90% | 1,985,730 | - |
| 310 | ARDT | Ardent Health, Inc. | 1.53B | -0.56% | 423,918 | 6.43B |
| 311 | AGL | agilon health, inc. | 1.53B | -5.31% | 174,019 | 5.82B |
| 312 | BLFS | BioLife Solutions, Inc. | 1.53B | -1.14% | 764,548 | 101.66M |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.52B | -2.90% | 791,757 | - |
| 314 | XNCR | Xencor, Inc. | 1.50B | -5.96% | 1,318,698 | 97.36M |
| 315 | NTLA | Intellia Therapeutics, Inc. | 1.49B | -3.70% | 2,650,733 | 66.09M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.49B | -2.57% | 335,545 | 20.00M |
| 317 | PAHC | Phibro Animal Health Corporation | 1.47B | -0.33% | 205,472 | 1.50B |
| 318 | ALVO | Alvotech | 1.47B | 15.41% | 1,720,001 | 562.04M |
| 319 | XERS | Xeris Biopharma Holdings, Inc. | 1.46B | -4.04% | 1,623,823 | 314.85M |
| 320 | ATEC | Alphatec Holdings, Inc. | 1.46B | -1.45% | 1,669,169 | 787.08M |
| 321 | VIR | Vir Biotechnology, Inc. | 1.46B | -2.70% | 1,126,881 | 65.50M |
| 322 | INSP | Inspire Medical Systems, Inc. | 1.45B | 0.38% | 672,276 | 915.25M |
| 323 | HROW | Harrow, Inc. | 1.45B | -0.44% | 261,493 | 268.68M |
| 324 | AHCO | AdaptHealth Corp. | 1.44B | 1.12% | 745,899 | 3.29B |
| 325 | PNTG | The Pennant Group, Inc. | 1.40B | -1.97% | 217,014 | 1.02B |
| 326 | PRGO | Perrigo Company plc | 1.40B | -1.94% | 2,880,304 | 4.18B |
| 327 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -27.16% | 7,447,452 | 42.95M |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.74% | 427,771 | - |
| 329 | CNMD | CONMED Corporation | 1.39B | -1.45% | 641,517 | 1.37B |
| 330 | SVRA | Savara Inc. | 1.38B | -1.44% | 1,168,541 | - |
| 331 | AHG | Akso Health Group | 1.35B | -1.26% | 4,337 | 13.83M |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.34B | -1.38% | 277,444 | 95.13M |
| 333 | TNDM | Tandem Diabetes Care, Inc. | 1.34B | 2.58% | 1,833,787 | 1.03B |
| 334 | PSNL | Personalis, Inc. | 1.33B | 3.09% | 2,744,548 | 64.52M |
| 335 | ABSI | Absci Corporation | 1.32B | 1.83% | 2,085,549 | 1.84M |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.30B | -3.11% | 681,796 | 3.42B |
| 337 | AORT | Artivion, Inc. | 1.30B | -3.04% | 614,645 | 458.69M |
| 338 | AZTA | Azenta, Inc. | 1.30B | -2.33% | 456,575 | 596.48M |
| 339 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -2.75% | 934,029 | 1.65B |
| 340 | AVLN | Avalyn Pharma Inc. | 1.28B | -1.77% | 126,781 | - |
| 341 | ETON | Eton Pharmaceuticals, Inc. | 1.27B | -5.32% | 484,528 | 86.93M |
| 342 | CERT | Certara, Inc. | 1.26B | 4.11% | 4,441,840 | 419.75M |
| 343 | FRNM | Freenome, Inc. | 1.26B | 11.61% | 1,264,190 | 34.24M |
| 344 | MNKD | MannKind Corporation | 1.25B | -4.87% | 5,404,120 | 360.78M |
| 345 | ARDX | Ardelyx, Inc. | 1.22B | -1.79% | 2,762,665 | 427.68M |
| 346 | AKTS | Aktis Oncology, Inc. | 1.22B | -4.04% | 278,383 | 8.28M |
| 347 | TDOC | Teladoc Health, Inc. | 1.22B | 1.98% | 8,564,816 | 2.49B |
| 348 | STAA | STAAR Surgical Company | 1.21B | 0.58% | 1,477,649 | 290.38M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -3.16% | 108,220 | 1.30M |
| 350 | NVAX | Novavax, Inc. | 1.20B | -1.61% | 3,405,997 | 596.34M |
| 351 | USPH | U.S. Physical Therapy, Inc. | 1.20B | -1.34% | 437,289 | 787.69M |
| 352 | IMTX | Immatics N.V. | 1.18B | -5.87% | 211,633 | 43.00M |
| 353 | OMDA | Omada Health, Inc. | 1.18B | 0.76% | 1,526,035 | 283.30M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.17B | -1.25% | 594,990 | - |
| 355 | IRMD | IRADIMED CORPORATION | 1.16B | -4.57% | 307,998 | 86.34M |
| 356 | LBRX | LB Pharmaceuticals Inc | 1.15B | -2.00% | 338,246 | - |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | -1.64% | 288,491 | 796.33M |
| 358 | VOR | Vor Biopharma Inc. | 1.15B | -2.98% | 904,879 | - |
| 359 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | -4.90% | 1,238,821 | - |
| 360 | QDEL | QuidelOrtho Corporation | 1.14B | 1.21% | 739,523 | 2.66B |
| 361 | SDGR | Schrödinger, Inc. | 1.13B | -1.37% | 1,218,111 | 254.91M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 0.53% | 775,582 | - |
| 363 | BVS | Bioventus Inc. | 1.10B | -0.08% | 774,019 | 576.30M |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.10B | 0.69% | 115,644 | - |
| 365 | MGTX | MeiraGTx Holdings plc | 1.09B | -1.59% | 516,765 | 79.76M |
| 366 | WVE | Wave Life Sciences Ltd. | 1.09B | -4.34% | 2,866,718 | 65.37M |
| 367 | DRTS | Alpha Tau Medical Ltd. | 1.06B | -0.84% | 272,113 | - |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.06B | 3.44% | 1,177,805 | 322.02M |
| 369 | ANRO | Alto Neuroscience, Inc. | 1.05B | -5.45% | 323,668 | - |
| 370 | CRON | Cronos Group Inc. | 1.05B | -2.08% | 728,448 | 159.54M |
| 371 | GDRX | GoodRx Holdings, Inc. | 1.04B | -3.15% | 712,089 | 787.89M |
| 372 | PCRX | Pacira BioSciences, Inc. | 1.04B | -2.08% | 540,070 | 734.86M |
| 373 | IVA | Inventiva S.A. | 1.03B | -3.03% | 1,352,865 | 7.94M |
| 374 | EYPT | EyePoint, Inc. | 1.03B | -4.74% | 1,711,083 | 7.61M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 2,767,750 | 69.64M |
| 376 | NUTX | Nutex Health Inc. | 1.01B | -0.86% | 157,448 | 879.95M |
| 377 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -5.82% | 839,529 | - |
| 378 | GMRS | GMR Solutions Inc. | 1.00B | 2.88% | 253,632 | 5.83B |
| 379 | LMRI | Lumexa Imaging Holdings, Inc. | 1.00B | 1.56% | 340,061 | 1.03B |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 1.00B | -3.13% | 709,777 | - |
| 381 | APMD | Apnimed, Inc. | 995.58M | 56.25% | 3,444,667 | 120.15M |
| 382 | OPK | OPKO Health, Inc. | 985.15M | -1.12% | 2,828,713 | 587.90M |
| 383 | AVTX | Avalo Therapeutics, Inc. | 965.48M | -5.88% | 923,877 | 59.00K |
| 384 | REPL | Replimune Group, Inc. | 940.40M | 107.02% | 33,629,890 | - |
| 385 | SANA | Sana Biotechnology, Inc. | 938.69M | -3.69% | 2,308,119 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 925.13M | -2.63% | 509,555 | 13.73M |
| 387 | ODTX | Odyssey Therapeutics, Inc. | 906.33M | 2.77% | 183,243 | 1.06M |
| 388 | AMPH | Amphastar Pharmaceuticals, Inc. | 879.21M | -2.16% | 367,423 | 720.53M |
| 389 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 1,774,877 | 238.37M |
| 390 | TBPH | Theravance Biopharma, Inc. | 873.82M | 0.06% | 369,695 | 109.78M |
| 391 | INMD | InMode Ltd. | 870.26M | 0.26% | 472,048 | 374.64M |
| 392 | ABUS | Arbutus Biopharma Corporation | 857.31M | -1.59% | 1,167,946 | 191.45M |
| 393 | OMER | Omeros Corporation | 856.92M | -0.75% | 1,309,589 | 9.89M |
| 394 | CSTL | Castle Biosciences, Inc. | 855.39M | 4.52% | 1,757,819 | 357.28M |
| 395 | ANNX | Annexon, Inc. | 834.78M | -3.32% | 2,800,726 | - |
| 396 | GERN | Geron Corporation | 827.56M | -3.73% | 19,589,837 | 196.12M |
| 397 | HSTM | HealthStream, Inc. | 819.19M | -0.57% | 155,254 | 311.78M |
| 398 | GLAS | Glass House Brands Inc. | 810.77M | -3.74% | 333,724 | 177.68M |
| 399 | DBVT | DBV Technologies S.A. | 799.95M | -2.24% | 351,681 | 5.04M |
| 400 | KURA | Kura Oncology, Inc. | 799.86M | -3.22% | 1,169,781 | 71.64M |
| 401 | SSII | SS Innovations International, Inc. | 796.52M | -0.25% | 33,112 | 48.47M |
| 402 | SLDB | Solid Biosciences Inc. | 793.50M | -5.06% | 1,060,556 | - |
| 403 | SIBN | SI-BONE, Inc. | 787.64M | -1.28% | 369,673 | 206.22M |
| 404 | TENX | Tenax Therapeutics, Inc. | 784.76M | -9.27% | 1,784,928 | - |
| 405 | AURA | Aura Biosciences, Inc. | 773.20M | -1.41% | 294,062 | - |
| 406 | AVR | Anteris Technologies Global Corp. | 764.05M | -4.85% | 1,034,826 | 1.85M |
| 407 | DSGN | Design Therapeutics, Inc. | 760.73M | -3.49% | 628,260 | - |
| 408 | SGP | SpyGlass Pharma, Inc. | 753.25M | -0.84% | 61,842 | - |
| 409 | CADL | Candel Therapeutics, Inc. | 733.44M | 1.42% | 1,117,469 | - |
| 410 | ACRS | Aclaris Therapeutics, Inc. | 726.25M | -2.26% | 1,638,334 | 8.37M |
| 411 | MNPR | Monopar Therapeutics Inc. | 725.81M | -5.50% | 431,271 | - |
| 412 | DRUG | Bright Minds Biosciences Inc. | 721.25M | -1.84% | 212,595 | - |
| 413 | PHAR | Pharming Group N.V. | 715.03M | -6.23% | 26,687 | 366.48M |
| 414 | FTH | Faeth Therapeutics, Inc. | 702.21M | -5.48% | 225,956 | - |
| 415 | EVO | Evotec SE | 697.26M | -1.04% | 34,100 | 859.03M |
| 416 | IRWD | Ironwood Pharmaceuticals, Inc. | 696.31M | 13.40% | 3,571,886 | 361.51M |
| 417 | PHAT | Phathom Pharmaceuticals, Inc. | 695.01M | -3.10% | 3,312,139 | 239.66M |
| 418 | OCS | Oculis Holding AG | 682.99M | 0.89% | 204,845 | 1.40M |
| 419 | CLYM | Climb Bio, Inc. | 681.40M | -1.49% | 653,699 | - |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 681.06M | -3.28% | 174,912 | 299.77M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 678.43M | -5.45% | 158,601 | - |
| 422 | CTMX | CytomX Therapeutics, Inc. | 674.88M | -5.49% | 3,502,360 | 35.54M |
| 423 | CBLL | CeriBell, Inc. | 671.21M | 0.28% | 410,686 | 95.07M |
| 424 | PHR | Phreesia, Inc. | 663.24M | 1.13% | 660,587 | 495.59M |
| 425 | ACHV | Achieve Life Sciences, Inc. | 659.07M | 1.90% | 1,181,692 | - |
| 426 | NGNE | Neurogene Inc. | 655.40M | -2.11% | 162,880 | 925.00K |
| 427 | ALLO | Allogene Therapeutics, Inc. | 648.89M | -4.57% | 5,521,843 | 22.00K |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 648.07M | -4.82% | 368,245 | - |
| 429 | GYRE | Gyre Therapeutics, Inc. | 641.06M | -1.03% | 47,589 | 117.05M |
| 430 | BWAY | BrainsWay Ltd. | 640.41M | -0.13% | 179,575 | 56.22M |
| 431 | TCMD | Tactile Systems Technology, Inc. | 635.41M | -0.11% | 150,363 | 343.52M |
| 432 | AGMB | AgomAb Therapeutics NV | 633.82M | 0.86% | 54,093 | - |
| 433 | CBIO | Crescent Biopharma, Inc. | 619.33M | -3.66% | 292,363 | 11.88M |
| 434 | TLRY | Tilray Brands, Inc. | 615.69M | 8.10% | 6,391,576 | 915.45M |
| 435 | ANGO | AngioDynamics, Inc. | 611.31M | 0.14% | 467,584 | 320.17M |
| 436 | MDXG | MiMedx Group, Inc. | 601.99M | -3.28% | 2,987,491 | 355.17M |
| 437 | RGNX | REGENXBIO Inc. | 597.90M | -4.25% | 1,157,433 | 87.82M |
| 438 | IMMX | Immix Biopharma, Inc. | 592.30M | -2.69% | 1,578,095 | - |
| 439 | CRMD | CorMedix Inc. | 590.74M | 0.53% | 637,205 | 400.05M |
| 440 | MPLT | MapLight Therapeutics, Inc. | 590.40M | -7.20% | 1,149,085 | - |
| 441 | CTNM | Contineum Therapeutics, Inc. | 582.75M | -1.65% | 449,367 | - |
| 442 | BBNX | Beta Bionics, Inc. | 577.22M | -10.09% | 2,004,574 | 119.01M |
| 443 | ZVRA | Zevra Therapeutics, Inc. | 562.18M | -1.35% | 971,429 | 122.29M |
| 444 | RLMD | Relmada Therapeutics, Inc. | 556.97M | -0.75% | 1,717,939 | - |
| 445 | ALT | Altimmune, Inc. | 552.31M | -4.70% | 3,892,079 | 36.00K |
| 446 | CTKB | Cytek Biosciences, Inc. | 544.98M | -2.09% | 608,893 | 204.17M |
| 447 | STTK | Shattuck Labs, Inc. | 542.13M | -1.67% | 660,438 | 1.00M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 532.17M | 1.09% | 716,312 | 88.24M |
| 449 | TECX | Tectonic Therapeutic, Inc. | 528.90M | -1.68% | 253,092 | - |
| 450 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | - | 629,806 | 151.40M |
| 451 | PRME | Prime Medicine, Inc. | 527.40M | -3.31% | 1,834,314 | 4.03M |
| 452 | WEAV | Weave Communications, Inc. | 520.36M | -0.30% | 601,548 | 248.72M |
| 453 | ANL | Adlai Nortye Ltd. | 520.00M | - | 120,408 | 5.00M |
| 454 | KIDS | OrthoPediatrics Corp. | 518.58M | 0.40% | 114,835 | 243.30M |
| 455 | ARVN | Arvinas, Inc. | 518.11M | -3.25% | 687,857 | 89.40M |
| 456 | ZURA | Zura Bio Limited | 515.84M | -1.99% | 541,147 | - |
| 457 | VSTM | Verastem, Inc. | 509.67M | -4.92% | 1,857,156 | 49.59M |
| 458 | SPRY | ARS Pharmaceuticals, Inc. | 509.43M | -8.88% | 2,083,370 | 98.99M |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 498.62M | -4.26% | 235,381 | - |
| 461 | SLN | Silence Therapeutics plc | 495.48M | -9.72% | 556,511 | 839.00K |
| 462 | RZLT | Rezolute, Inc. | 493.08M | -3.28% | 776,942 | - |
| 463 | ARTV | Artiva Biotherapeutics, Inc. | 490.74M | -3.16% | 361,923 | 251.00K |
| 464 | TOI | The Oncology Institute, Inc. | 485.92M | -4.14% | 1,005,358 | 545.76M |
| 465 | HELP | Cybin Inc. | 484.72M | -3.93% | 686,492 | - |
| 466 | ASMB | Assembly Biosciences, Inc. | 483.39M | -3.65% | 101,353 | 71.10M |
| 467 | OFIX | Orthofix Medical Inc. | 476.98M | 0.08% | 261,311 | 825.37M |
| 468 | SOPH | SOPHiA GENETICS SA | 475.69M | -1.56% | 78,332 | 81.18M |
| 469 | VREX | Varex Imaging Corporation | 471.62M | 1.08% | 314,625 | 857.50M |
| 470 | SI | Shoulder Innovations, Inc. | 471.59M | -1.94% | 79,167 | 53.89M |
| 471 | VALN | Valneva SE | 468.61M | -2.36% | 23,010 | 180.25M |
| 472 | QTTB | Q32 Bio Inc. | 466.70M | 0.77% | 386,806 | 53.74M |
| 473 | PROK | ProKidney Corp. | 465.17M | -2.53% | 809,053 | 889.00K |
| 474 | AQST | Aquestive Therapeutics, Inc. | 463.60M | -0.67% | 1,785,627 | 50.27M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 456.22M | -8.91% | 292,738 | 16.72M |
| 476 | FLGT | Fulgent Genetics, Inc. | 455.38M | -18.11% | 1,316,917 | 323.93M |
| 477 | CLPT | ClearPoint Neuro, Inc. | 448.04M | 2.47% | 605,187 | 40.61M |
| 478 | VMD | Viemed Healthcare, Inc. | 447.39M | -0.77% | 454,066 | 286.57M |
| 479 | KYTX | Kyverna Therapeutics, Inc. | 443.81M | -2.54% | 526,071 | - |
| 480 | NPCE | NeuroPace, Inc. | 439.47M | -6.25% | 332,009 | 99.53M |
| 481 | SGMT | Sagimet Biosciences Inc. | 439.06M | -2.74% | 616,133 | - |
| 482 | CABA | Cabaletta Bio, Inc. | 436.99M | -1.47% | 1,907,662 | - |
| 483 | PACB | Pacific Biosciences of California, Inc. | 434.84M | -5.41% | 3,139,195 | 160.03M |
| 484 | NNNN | Anbio Biotechnology | 434.52M | -7.91% | 33,073 | 8.65M |
| 485 | SRTA | Strata Critical Medical, Inc. | 434.36M | -1.38% | 760,760 | 228.58M |
| 486 | CERS | Cerus Corporation | 433.28M | -25.61% | 8,325,591 | 221.55M |
| 487 | NRC | NRC Health | 431.94M | 3.17% | 167,940 | 140.00M |
| 488 | SLBT | SL Science Holding Limited | 427.50M | -1.67% | 15,653 | 3.36M |
| 489 | IKT | Inhibikase Therapeutics, Inc. | 426.02M | -4.39% | 369,378 | 1.00 |
| 490 | PRTA | Prothena Corporation plc | 425.11M | -3.45% | 545,490 | 57.94M |
| 491 | DCTH | Delcath Systems, Inc. | 421.85M | 1.50% | 372,145 | 90.44M |
| 492 | KMDA | Kamada Ltd. | 418.44M | 0.56% | 70,186 | 181.68M |
| 493 | EPRX | Eupraxia Pharmaceuticals Inc. | 418.17M | -2.29% | 456,258 | - |
| 494 | OCGN | Ocugen, Inc. | 416.38M | -2.38% | 4,149,005 | 4.47M |
| 495 | OVID | Ovid Therapeutics Inc. | 414.34M | -6.33% | 1,745,353 | 7.12M |
| 496 | EVMN | Evommune, Inc. | 405.21M | -0.88% | 302,959 | 10.00M |
| 497 | PBYI | Puma Biotechnology, Inc. | 403.63M | 0.51% | 264,861 | 227.18M |
| 498 | BNTC | Benitec Biopharma Inc. | 402.29M | -1.26% | 107,525 | - |
| 499 | BIOA | BioAge Labs, Inc. | 401.85M | -63.62% | 9,979,965 | 10.32M |
| 500 | VTVT | vTv Therapeutics Inc. | 401.45M | -1.01% | 136,838 | 36.84M |